Phase II Evaluation of Oral Trimetrexate in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

Author： Fowler J.M.   Blessing J.A.   Burger R.A.   Malfetano J.H.  

Publisher： Academic Press

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.85, Iss.2, 2002-05, pp. : 311-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Hydroxyurea, Dacarbazine (DTIC), and Etoposide (VP-16) in Mixed Mesodermal Tumors of the Uterus: A Gynecologic Oncology Group Study

By Currie J.L.   Blessing J.A.   McGehee R.   Soper J.T.   Berman M.  

Gynecologic Oncology, Vol. 61, Iss. 1, 1996-04 ,pp. : 94-96

Academic Press

Access to resources Recommend Favorite

Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group

By Smith H.O.   Blessing J.A.   Vaccarello L.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 140-144

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Paclitaxel in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Sutton G.   Blessing J.A.   Ball H.  

Gynecologic Oncology, Vol. 74, Iss. 3, 1999-09 ,pp. : 346-349

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Etoposide in Leiomyosarcoma of the Uterus: A Gynecologic Oncology Group Study

By Thigpen T.   Blessing J.A.   Yordan E.   Valea F.   Vaccarello L.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 120-122

Academic Press

Access to resources Recommend Favorite

Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study

By Fracasso P.M.   Blessing J.A.   Wolf J.   Rocereto T.F.   Berek J.S.   Waggoner S.  

Gynecologic Oncology, Vol. 90, Iss. 1, 2003-07 ,pp. : 177-180

Elsevier

Access to resources Recommend Favorite